Associate Professor, Pediatrics, Perelman School of Medicine
Pediatric Hematology & Oncology
Dr. Edwin M. Horwitz, MD
|
|
Give Review
Edwin M. Horwitz, MD practices Pediatric Hematology & Oncology. He researched medicine at Indiana University School of Medicine. Indiana University School of Medicine is ranked 45 in research and 47 in primary care medicine He received awards:"Elected Member". Dr. Edwin M. Horwitz is a published physician. He published 42 publications, including: 'Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective.'
Publications
- Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective.
- Genomic and functional comparison of mesenchymal stromal Cells prepared using two isolation methods.
- Going back to class I: MHC and immunotherapies for childhood cancer.
- Tendon Progenitor Cells in Injured Tendons Have Strong Chondrogenic Potential: The CD105-Negative Subpopulation Induces Chondrogenic Degeneration.
- Effect of post remission therapy prior to reduced intensity conditioning allogeneic transplantation for acute Myeloid leukemia in first complete remission.
- Delayed Marrow Infusion in Mice Enhances Hematopoietic and Osteopoietic EnGraftment by Facilitating Transient Expansion of the Osteoblastic Niche.
- Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell enGraftment after radioablative conditioning.
- Frequent Mutations in SH2D1A (XLP) in Males Presenting With High-Grade Mature B-Cell Neoplasms.
- Transplanted Murine Long-term Repopulating Hematopoietic Cells Can Differentiate to Osteoblasts in the Marrow Stem Cell Niche.
- Advancing regenerative medicine the translational way.
- Improved isolation and expansion of bone marrow mesenchymal stromal Cells using a novel marrow filter device.
- Cytokine-induced osteopoietic differentiation of transplanted marrow Cells.
- Statins are active in acute lymphoblastic leukaemia (ALL): a therapy that may treat ALL and prevent avascular necrosis.
- Clinical outcomes following hematopoietic stem Cell transplantation for the treatment of mucopolysaccharidosis VI.
- Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers.
- MSCs in hematopoietic Cell transplantation.
- Building bone from blood vessels.
- Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium.
- Adipose-derived mesenchymal stem Cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy.
- Parabiotic heterogenetic pairing of Abcc6-/-/Rag1-/- mice and their wild-type counterparts halts ectopic mineralization in a murine model of pseudoxanthoma elasticum.
- Restoration and reversible expansion of the osteoblastic hematopoietic stem Cell niche after marrow radioablation.
- Heterogeneity of multipotent mesenchymal stromal Cells: from stromal Cells to stem Cells and vice versa.
- Clinical utility of computed tomography screening of chest, abdomen, and sinuses before hematopoietic stem Cell transplantation: the St. Jude experience.
- Donor Cell-derived osteopoiesis originates from a self-renewing stem Cell with a limited regenerative contribution after transplantation.
- Airway evaluation and management in 7 children with malignant infantile osteopetrosis before hematopoietic stem Cell transplantation.
- EBV lymphoproliferative disease of Host origin after haploidentical stem cell transplantation.
- Diagnostic yield of bronchoalveolar lavage is low in allogeneic hematopoietic stem cell recipients receiving immunosuppressive therapy or with acute Graft-versus-host ...
- Human bone marrow mesenchymal stromal Cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs.
- Report on the workshop "New Technologies in Stem Cell Research," Society for Pediatric Research, San Francisco, California, April 29, 2006.
- Quantitative bone mineral density assessment in malignant infantile osteopetrosis.
- Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem Cell transplant patients.
- Skeletons in the p53 tumor suppressor closet: genetic evidence that p53 blocks bone differentiation and development.
- Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children.
- Hematopoietic Cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation.
- Etiology and outcome of Graft failure in pediatric hematopoietic stem cell transplant recipients.
- Stem Cell plasticity: the growing potential of Cellular therapy.
- Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis.
- Stem Cell plasticity: a new image of the bone marrow stem Cell.
- Isolated allogeneic bone marrow-derived mesenchymal cells enGraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone.
- Reversal of obstructive sleep apnea in osteopetrosis following bone marrow transplantation.
- Mesenchymal stem/stromal Cells as a delivery platform in Cell and gene therapies.
Schools
Indiana University School of Medicine
Chldns Hospital and Washington University
Conditions Treated
- Anemia
- Chronic Myeloid Leukemia (CML)
- Graft vs Host Disease
- Lymphoma
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- Elected Member
Education
-
Indiana University School of Medicine
Hospital
-
Nationwide Children's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Jessica M. Gefvert, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kieuhoa T. Vo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keri A. Streby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah O'Brien, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bryce A. Kerlin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randal S. Olshefski, MD
This Doctor is OpenDoctor Recommended.
|